Company profile
UK company NI601946, incorporated on 28 January 2010.
ARC Regulatory Consulting
ARC is a niche provider of global regulatory and clinical research solutions to the precision medicine and in vitro diagnostic medical device industry. ARC is a trusted partner in the global ambition to improve patient care, leveraging our expertise in delivering high quality, accelerated clinical research for biomarker diagnostics.
Company number NI601946
Updated 07 Jul 2026 09:49
Financial period: 1 Feb 2024 to 31 Jan 2025
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
1 Nov 2024 to 31 Oct 2027
To develop a Regulatory Navigator software platform for the Precision Medicine / In Vitro Diagnostics Industry to assist clinical trial Sponsors in accessing in real-time, accurate information on global regulatory requirements and understanding the implications for their clinical development pipelines
1 Oct 2024 to 31 Mar 2025
In Vitro Diagnostics (IVDs) are an essential element of Precision Medicine. When a new drug is being developed for a condition such as cancer, an IVD is often required in order to support the selection of the most appropriate clinical trial subjects, and/or as a measure of the effectiveness of the drug. Driven by global regulatory authority regulations, t...
